ABBV vs MDXG

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

Score Change Explanation: The significant upward revision in score from 5.8 to 7.9 is primarily driven by the robust Q4 and full year 2025 earnings report. The company demonstrated strong financial progress with Q4 net sales growing 27% year-over-year and, crucially, reported positive GAAP net income of $15 million and adjusted EPS of $0.14. This tangible return to profitability and accelerated re...